Projet PRECeDI (Horizon 2020, appel à projets 2014)
Action : Staff Exchanges
Panel : Life Sciences
Statut du projet : CLOSED

The aim of the Personalized pREvention of Chronic DIseases consortium (PRECeDI) is to provide high-quality, multidisciplinary knowledge through training and research in Personalized Medicine (PM), with specific reference to prevention of chronic diseases. There is a large consensus that PM is a driver of innovation for research and health care, and also for the health care system and industry as a whole. In order to harness the potential of this new concept, the PRECeDI consortium provides a cohesive framework for training staff from academic and non-academic (NA) institutions on research topics related to PM, with specific reference to the prevention of chronic diseases where there is a lack of substantial evidence, though the potential is huge. The acquisition of skills from staff will come from dedicated secondments aimed at training on research topics not available at the home institutions, and attendance to courses, workshops, seminars, conferences. The goal of secondment is to enable staff to make informed decisions for appropriately serve health care systems, new biotech industries and policy makers at the dawn of the post-genomic era PRECeDI is a multidisciplinary group of institutions working on different facets of PM, from basic research, to economic evaluations, health service organization, and ethical, social, and policy issues. The consortium is embedded in existing cooperation structures, such as the PerMed project and the Erasmus Mundus ERAWEB II program, with additional leading SMEs in Europe and Canada as beneficiaries. The consortium consists of 8 beneficiaries and 3 partners, of which 7 are academic institutions and 4 NA, including 2 SMEs. During 4-years, 23 ESRs and 7 ERs will be seconded to 11 institutions, where researchers will be supported by a team of leading EU scientists in PM-related disciplines. In the long run, PRECeDI will foster the integration of PM in the field of prevention, thus contributing to better health for Europe’s citizen

Mots clés : personalised medicine, genomics, chronic disease, health systems

Participants :
- Amsterdam University Medical Centers (Pays-Bas) — Partner, beneficiary, Recherche, subvention : 63000.0 €
- McGill University (Canada) — Partner, organization partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Università Cattolica del Sacro Cuore (Italie) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 238500.0 €
- Sapienza University of Rome (Italie) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 180000.0 €
- Myriad genetics srl (Italie) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 0.0 €
- Linkcare health services sl (Espagne) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 54000.0 €
- University of Debrecen (Hongrie) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 90000.0 €
- Vrije Universiteit Amsterdam (Pays-Bas) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Erasmus MC (Pays-Bas) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 108000.0 €
- Mount Sinai Health System (Etats-Unis) — Partner, organization partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- European Public Health Association (Pays-Bas) — Partner, beneficiary, Autres, subvention : 0.0 €
- Better value healthcare ltd (Royaume-Uni) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 58500.0 €